المسؤولية المدنية لمصنع الدواء في التشريع الوطني

dc.contributor.authorجابر, محمد أمين
dc.contributor.authorولد كرانجر, فاطمة الزهراء
dc.contributor.authorبردان, صفية
dc.date.accessioned2024-02-07T10:02:08Z
dc.date.available2024-02-07T10:02:08Z
dc.date.issued2023
dc.description.abstractThe pharmaceutical industry has been given the utmost importance in Algerian legislation due to its specificity and sensitive nature, as well as its complex components and sometimes toxic character Manufacture and circulation of drugs, and this can only be done 'by imposing a number of and legal obligations on drug producers under pain of sanction in the form of the drug manufacturer, whether it is a natural person or a legal person when it comes to the pharmaceutical company that produces the drug. In this context, the Algerian legislator introduced objective liability through article 140 bis of the Algerian Civil Code to protect consumers more than pharmaceutical productsen_US
dc.identifier.urihttp://dspace.univ-temouchent.edu.dz/handle/123456789/2015
dc.language.isootheren_US
dc.titleالمسؤولية المدنية لمصنع الدواء في التشريع الوطنيen_US
dc.typeThesisen_US

Fichiers

Bundle original

Voici les éléments 1 - 1 sur 1
En cours de chargement...
Vignette d'image
Nom:
مذكرة.pdf
Taille:
14.88 MB
Format:
Adobe Portable Document Format
Description:

Bundle de license

Voici les éléments 1 - 1 sur 1
En cours de chargement...
Vignette d'image
Nom:
license.txt
Taille:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections